NCT04358016View on ClinicalTrials.gov

Terlipression Prevent Developing of Acute Kidney Injury During Upper-gastroentestinal Bleeding

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

January 1, 2020

Study Completion Date

March 1, 2020

Conditions
Cirrhosis, LiverUpper Gastrointestinal Bleeding
Interventions
DRUG

Terlipressin

Evaluate the effect of Terlipression on the occurance of acute kidney injury in patients with upper-gastroentestinal bleeding

DRUG

Somatostatin

Somatostatin

Trial Locations (1)

200433

Changhai hospital, Shanghai

All Listed Sponsors
lead

Changhai Hospital

OTHER

NCT04358016 - Terlipression Prevent Developing of Acute Kidney Injury During Upper-gastroentestinal Bleeding | Biotech Hunter | Biotech Hunter